These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 31342515

  • 1. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
    Crespi J, Bratbak D, Dodick DW, Matharu M, Jamtøy KA, Tronvik E.
    Headache; 2019 Sep; 59(8):1229-1239. PubMed ID: 31342515
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study.
    Jamtøy KA, Tronvik E, Bratbak DF, Crespi J, Stovner LJ, Aschehoug I, Thorstensen WM.
    Acta Otolaryngol; 2021 Oct; 141(10):934-940. PubMed ID: 34633904
    [Abstract] [Full Text] [Related]

  • 4. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.
    Bratbak DF, Nordgård S, Stovner LJ, Linde M, Dodick DW, Aschehoug I, Folvik M, Tronvik E.
    Cephalalgia; 2017 Apr; 37(4):356-364. PubMed ID: 27154997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study.
    Jamtøy KA, Thorstensen WM, Stovner LJ, Rosén A, Maarbjerg S, Bratbak D, Simpson MR, Tronvik E.
    Cephalalgia; 2023 Jul; 43(7):3331024231187132. PubMed ID: 37435807
    [Abstract] [Full Text] [Related]

  • 7. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C.
    J Headache Pain; 2014 Sep 27; 15(1):65. PubMed ID: 25263254
    [Abstract] [Full Text] [Related]

  • 8. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M.
    Trials; 2015 Dec 03; 16():550. PubMed ID: 26634453
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U, Ilhan S, Alp R, Sur H.
    Clin Neuropharmacol; 2005 Dec 03; 28(4):161-2. PubMed ID: 16062093
    [Abstract] [Full Text] [Related]

  • 10. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C.
    Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517
    [Abstract] [Full Text] [Related]

  • 11. A new target for the treatment of trigeminal neuralgia with botulinum toxin type A.
    Wu C, Xie N, Liu H, Zhang H, Zhang L, Lian Y.
    Neurol Sci; 2018 Mar 14; 39(3):599-602. PubMed ID: 29086125
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.
    Türk Börü Ü, Duman A, Bölük C, Coşkun Duman S, Taşdemir M.
    Medicine (Baltimore); 2017 Sep 14; 96(39):e8133. PubMed ID: 28953646
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sphenopalatine Ganglion Block with Botulinum Neurotoxin for Treating Trigeminal Neuralgia Using CAD/CAM-Derived Injection Guide.
    Yoshida K.
    J Oral Facial Pain Headache; 2020 Sep 14; 34(2):135–140. PubMed ID: 31560737
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.
    Cady R, Saper J, Dexter K, Manley HR.
    Headache; 2015 Jan 14; 55(1):101-16. PubMed ID: 25338927
    [Abstract] [Full Text] [Related]

  • 17. Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine.
    Simmonds L, Jamtøy KA, Aschehoug I, Hara S, Meisingset TW, Matharu MS, Tronvik E, Bratbak DF.
    Cephalalgia; 2024 Aug 14; 44(8):3331024241273967. PubMed ID: 39165124
    [Abstract] [Full Text] [Related]

  • 18. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O'Hare P, Whitmore K.
    Female Pelvic Med Reconstr Surg; 2015 Aug 14; 21(5):277-82. PubMed ID: 25900057
    [Abstract] [Full Text] [Related]

  • 19. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
    Zhang H, Lian Y, Xie N, Chen C, Zheng Y.
    J Headache Pain; 2017 Aug 10; 18(1):81. PubMed ID: 28799056
    [Abstract] [Full Text] [Related]

  • 20. Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
    Anderson CC, Iser CR, Hirte IL, Boddu S, Girardo ME, VanderPluym JH, Starling AJ.
    Headache; 2024 Jun 10; 64(6):663-673. PubMed ID: 38700250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.